TGF-β: duality of function between tumor prevention and carcinogenesis. - Wikidata - awgldk - TriplyDB

TGF-β: duality of function between tumor prevention and carcinogenesis.

TGF-β: duality of function between tumor prevention and carcinogenesis.

http://www.wikidata.org/entity/Q37634488

about

Bladder Cancer Stem-Like Cells: Their Origin and Therapeutic Perspectives Hepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genes Regulation of Bim in Health and Disease Cancer research in need of a scientific revolution: Using 'paradigm shift' as a method of investigation Extracellular matrix as a contextual determinant of transforming growth factor-β signaling in epithelial-mesenchymal transition and in cancer TGF-β Signaling in Bone Remodeling and Osteosarcoma Progression Utilizing past and present mouse systems to engineer more relevant pancreatic cancer models Comprehensive functional characterization of cancer-testis antigens defines obligate participation in multiple hallmarks of cancer Dual function of TGFβ in lens epithelial cell fate: implications for secondary cataract.Constitutively active transforming growth factor β receptor 1 in the mouse ovary promotes tumorigenesis Transcriptional regulation by normal epithelium of premalignant to malignant progression in Barrett's esophagus Active transforming growth factor-β2 in the aqueous humor of posterior polymorphous corneal dystrophy patients.Intratumoral Lentivector-Mediated TGF-β1 Gene Downregulation As a Potent Strategy for Enhancing the Antitumor Effect of Therapy Composed of Cyclophosphamide and Dendritic Cells Haploinsufficient tumor suppressor genes.Activin signaling is an essential component of the TGF-β induced pro-metastatic phenotype in colorectal cancer.TGFBR1 and cancer susceptibility.New radiotracers for imaging of vascular targets in angiogenesis-related diseases.Cutting the brakes and flooring the gas: how TMEPAI turns TGF-β into a tumor promoter.Vicious cycle of TGF-β signaling in tumor progression and metastasis.Binding of a Smad4/Ets-1 complex to a novel intragenic regulatory element in exon12 of FPGS underlies decreased gene expression and antifolate resistance in leukemia Reciprocity in breast cancer progression.Association of TGF-β2 levels in breast milk with severity of breast biopsy diagnosis.P21 activated kinase-1 mediates transforming growth factor β1-induced prostate cancer cell epithelial to mesenchymal transition.Extracellular molecules involved in cancer cell invasion Multiple functional risk variants in a SMAD7 enhancer implicate a colorectal cancer risk haplotype.Simultaneous irradiation of fibroblasts and carcinoma cells repress the secretion of soluble factors able to stimulate carcinoma cell migration.Integrated approaches to miRNAs target definition: time-series analysis in an osteosarcoma differentiative model.TGF-β Blockade Reduces Mortality and Metabolic Changes in a Validated Murine Model of Pancreatic Cancer Cachexia Quantitative proteomic analysis of single or fractionated radiation-induced proteins in human breast cancer MDA-MB-231 cells Association between Prediagnostic Allergy-Related Serum Cytokines and Glioma.Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Induces the Oncogenic miR-17-92 Cluster and Down-Regulates TGF-β Signaling.Transforming Growth Factor TGFβ Increases Levels of Microtubule-Associated Protein MAP1S and Autophagy Flux in Pancreatic Ductal Adenocarcinomas The anti-oxidative transcription factor Nuclear factor E2 related factor-2 (Nrf2) counteracts TGF-β1 mediated growth inhibition of pancreatic ductal epithelial cells -Nrf2 as determinant of pro-tumorigenic functions of TGF-β1.Mutational Profiles Reveal an Aberrant TGF-β-CEA Regulated Pathway in Colon Adenomas Serum IL-10 Predicts Worse Outcome in Cancer Patients: A Meta-Analysis TCR signaling intensity controls CD8+ T cell responsiveness to TGF-β.Activin and TGFβ use diverging mitogenic signaling in advanced colon cancer Homoharringtonine targets Smad3 and TGF-β pathway to inhibit the proliferation of acute myeloid leukemia cells.TGF-ß isoforms in cancer: Immunohistochemical expression and Smad-pathway-activity-analysis in thirteen major tumor types with a critical appraisal of antibody specificity and immunohistochemistry assay validity.Epitelial-to-mesenchimal transition and invasion are upmodulated by tumor-expressed granzyme B and inhibited by docosahexaenoic acid in human colorectal cancer cells.

P2860

Q26771263-161CEAB3-1065-497C-9A8A-095B2AE2971F Q26772317-28C0F1E2-F39A-43C0-8BC6-3FEEE8ABCF72 Q26781203-5F6570C2-7DA1-4327-B8EA-5AD1EB514A83 Q26786406-51ABF5B7-0642-4E26-BD50-D6BB80BCDF37 Q27005909-64662B58-CE22-4707-B42F-CD89E805C0D2 Q28076815-A5DFDC83-1D22-4B5B-8335-8AA5D990A161 Q28083091-5DDDF6F8-7191-4A30-B91F-0DA4DBEE5B9F Q28975773-9B5442B7-5518-4943-A460-1ABE31B3F44F Q30352305-0376325E-C393-496D-A7E9-67468DBE9A5D Q30354729-652F0FD2-9AC3-4C23-B630-32DF0368B6F1 Q30820949-3D94D0BF-18B3-43C0-8DF7-0C0764636D04 Q33570591-6D2DF713-2EAE-4C15-BA73-10A9495E5BE1 Q33858506-48F9157A-2182-4476-9503-75CB33021925 Q33864922-5D6A147E-AE9E-4AE7-B61A-B3DF02D9E570 Q33912255-29349B36-F31F-42FA-939A-5D74858E57A8 Q33957710-E07B7DAA-1722-48A5-B486-EA0D491D9D7A Q34216877-EEDBA8B7-9CEC-43DA-A358-ECA8DC81660E Q34405475-7E66E4DF-ED31-4B5D-8B96-5E8E8018C236 Q34448186-3F805402-4BC5-4D80-B475-87C7A2C313C2 Q34619287-9A7781FB-582A-42D4-A35A-230146D5CFD1 Q34956987-49AE7ECC-5DE2-4050-B935-788DC3C6006A Q35102289-606464A4-2E2D-40A0-88AE-6BADEC8E7C29 Q35235907-7FC0F202-0793-4881-BA7C-AC27C93E6D36 Q35237503-C69C5DA4-EF71-4EB6-8498-1F9B448D5328 Q35399193-122A937C-B8C2-42A9-A357-493A659EFE89 Q35551808-785DFE49-FFC9-48B8-B80F-188726D4D383 Q35678071-CF2F4FE6-3246-40A0-96CA-5E290B667AF7 Q35690582-1317D6E3-EF34-46F9-A4DE-F8DFA36EA5CE Q35693267-8A323719-DCCF-4327-9604-628865A5CD70 Q35767586-8B0BC194-7F90-4662-BC0E-064851A0AF76 Q35834474-689DE40F-764F-427A-A8EE-1A0803FC9CC5 Q35841939-D9275ABA-61D2-40F1-B791-E5107EEE9313 Q35936030-A75729EC-909A-4DAD-A9C5-A4AE99383A02 Q35995712-A288D527-A4B7-46CB-8CA2-91E5A1B203C5 Q36127128-8C0947E2-0B7D-42D4-A3D0-4824D8FD9355 Q36143408-65CF14C9-AD2A-41ED-8106-2BE7BAD0A179 Q36203725-D3953376-3C12-4C14-8ACE-1616E7195F0D Q36358267-6151664B-F6A0-42F9-B31E-1297B55A3C6F Q36413606-AF6941E3-6D81-4537-A13C-C4A69D1B9627 Q36531360-BD467520-D02A-471B-A3ED-57F9B7DD3678

P2860

TGF-β: duality of function between tumor prevention and carcinogenesis.

http://www.wikidata.org/entity/Q37634488

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

TGF-β: duality of function between tumor prevention and carcinogenesis.

@en

TGF-β: duality of function between tumor prevention and carcinogenesis.

@nl

type

label

TGF-β: duality of function between tumor prevention and carcinogenesis.

@en

TGF-β: duality of function between tumor prevention and carcinogenesis.

@nl

prefLabel

TGF-β: duality of function between tumor prevention and carcinogenesis.

@en

TGF-β: duality of function between tumor prevention and carcinogenesis.

@nl

P1433

Q37634488-AF330E46-7227-40B4-9043-953EB2EB70A9

P1476

Q37634488-A2127CD0-C86E-427E-9C44-A384D3B9698D

P2093

Q37634488-20F51C0F-D49D-4850-8DE0-5FA0A161E4DF

Q37634488-30817278-7B6A-426D-AD19-D8F9F302B9B1

Q37634488-4574BBCE-CDDC-44FC-BF25-15D89CDDE9E3

Q37634488-6A863367-4323-4F0E-844F-26C121ACE9EF

Q37634488-8DEE595A-F613-4B39-956B-120C7FA0AFFE

Q37634488-B2557847-2409-4AA8-BEED-4DA8D5116840

Q37634488-EBE8909A-171A-4ABC-9D97-F77B3D72A669

P2860

Q37634488-087F05D2-0B26-4857-9563-70F2841A61C1

Q37634488-0BE63092-4BE7-4722-8896-1F4545384E4E

Q37634488-0D8607AD-5715-4BD7-9349-45DEFB4935FD

Q37634488-0F625CF2-BECF-49ED-9652-A8B40DB92B9C

Q37634488-0FFFCC05-60E0-41D8-9088-8BDA36A8F541

Q37634488-104B6438-43D9-4926-8AC7-59B1ACD1083E

Q37634488-1220A7AD-0296-4ADE-9598-648FACCEFF81

Q37634488-125CB4C8-F846-4C3A-9B3A-5FAF8B2E2E2E

Q37634488-141EF80C-6106-4642-BE86-A600D5178EC9

Q37634488-17561D29-B5BC-4DA3-B554-BFBD8331B04B

P304

Q37634488-E63F6112-1473-44A2-8310-D4B51E30B0BC

P31

Q37634488-E65194D7-1E34-46CB-9E8A-4202407A3C0D

P356

Q37634488-851C9575-BE57-4FB1-BC1D-2C7C2330D21B

P407

Q37634488-7CC14432-F6C4-4493-B679-68C99CFFC4F9

P433

Q37634488-7C090FA0-89AA-4CCA-82C9-9385F9BAA45A

P478

Q37634488-C3080A9A-B572-4D67-9E8C-21327C4BF6D6

P50

Q37634488-5DE596A4-76F9-453C-B485-224C53CC51F5

Q37634488-F344F477-D876-4169-B594-3AE6EE8248A3

P577

Q37634488-21151E58-2062-42B7-874E-34C1CA6F212D

P5875

Q37634488-4272D732-5EDE-4A69-8836-FF393347F888

P698

Q37634488-CF05E6DA-52AD-4974-843D-B5DC89F75450

P932

Q37634488-9381F3C9-513C-4DC2-B443-B7011DB541C9

P356

P1433

Journal of the National Cancer Institute

P1476

TGF-β: duality of function between tumor prevention and carcinogenesis

@en

P2093

Barbara Jung

http://www.w3.org/2001/XMLSchema#string

Boris Pasche

http://www.w3.org/2001/XMLSchema#string

Chung Lee

http://www.w3.org/2001/XMLSchema#string

Daniel R Principe

http://www.w3.org/2001/XMLSchema#string

Hidayatullah G Munshi

http://www.w3.org/2001/XMLSchema#string

Jennifer A Doll

http://www.w3.org/2001/XMLSchema#string

Paul J Grippo

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic progression and the waiting time to cancer

Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.

SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor

Hallmarks of Cancer: The Next Generation

Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation

Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation

TGF-beta-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation

Controlling the angiogenic switch: a balance between two distinct TGF-b receptor signaling pathways

Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas

Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression

P304

djt369

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/DJT369

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

106

http://www.w3.org/2001/XMLSchema#string

P50

Laurent Bartholin

P577

2014-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260132034

http://www.w3.org/2001/XMLSchema#string

P698

24511106

http://www.w3.org/2001/XMLSchema#string

P932

3952197

http://www.w3.org/2001/XMLSchema#string